EVAg

Infectious cell culture supernatant containing SARS-CoV-2, JN.1. Isolated from throat/Nasopharynx and cultured on Calu-3 cells.

Infectious cell culture supernatant containing SARS-CoV-2, JN.1.4. Isolated from throat/Nasopharynx and cultured on Calu-3 cells.

Infectious cell culture supernatant containing SARS-CoV-2, JN.1. Isolated from throat/Nasopharynx and cultured on Calu-3 cells.

Infectious cell culture supernatant containing SARS-CoV-2, JN.1.19. Isolated from throat/Nasopharynx and cultured on Calu-3 cells.

Human monoclonal recombinant IgG1 targeting the S2 domain of HCoV-OC43 Spike domain, as determined by ELISA.

Infectious cell culture supernatant containing SARS-CoV-2 (hCoV-19/Netherlands/NH-EMC-1720/2021, Omicron variant, lineage B.1.1.529.

Vial containing RNA of SARS-CoV-2 (hCoV-19/Netherlands/NH-EMC-1720/2021, Omicron variant, lineage B.1.1.529. This strain has been cultivated on Calu-3 cells. . GSAID reference: hCoV-19/Netherlands/NH-RIVM-71084/2021.

Infectious cell culture supernatant of SARS-CoV-2 from The Netherlands

Panel consists of (cell-culture) RNA from different coronaviruses (HCoV-Nl63, HCoV-229E, HCoV-OC43, MERS-CoV and SARS-CoV) and is intended for use as control of specificity of molecular assays. This panel contains sufficient RNA for t least 5 experiments. "Disclaimer: Import permit may be needed in your country for SARS-CoV full virus RNA. If yes, please indicate so in your online enquiry". Product for Alphacoronavirus and Betacoronavirus. ------------------ NB: indicated price is only valid for non-profit laboratories. Commercial users will be contacted about pricing.